["{\n\"step_by_step_thinking\": \"The question asks if TAMs (T-cell-targeted immunotherapy) are good anticancer therapeutic targets. The documents provided give an overview of various therapies being developed for cancer treatment. T-cell research is highlighted as one area with rapid advances. Immunotoxins, which combine the properties of antibodies and toxins, are mentioned as a new generation of protein therapeutics. Additionally, advances in drug delivery and targeting are discussed, including the use of monoclonal antibodies and liposomes to improve specificity of delivery to tumor tissue. Based on this information, it can be inferred that T-cell-targeted immunotherapy is being developed as an anticancer therapeutic target.\",\n\"answer_choice\": A"]